Cited by — Individualized Ofatumumab versus Fixed Low‐Dose Rituximab in MuSK‐Antibody‐Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Individualized Ofatumumab versus Fixed Low‐Dose Rituximab in MuSK‐Antibody‐Positive Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
No admitted local citation edges point to this work yet.
